Sveriges mest populära poddar

What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma

56 min•8 november 2024

Dr Gilles Salles from the Memorial Sloan Kettering Cancer Center in New York, New York, reviews current and novel EZH1/2 inhibitor-based treatment strategies for follicular lymphoma.

Fler avsnitt av Hematologic Oncology Update

Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review

1 apr.•25 min

CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson

23 mars•24 min

Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review

21 mars•29 min

CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah

13 mars•1 tim 3 min

Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting

11 mars•47 min

Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review

9 mars•19 min

Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review

4 mars•24 min

Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators

18 feb.•58 min

Relapsed/Refractory Multiple Myeloma — Microlearning Activity 2 with Dr Sagar Lonial: ASH 2025 Review

13 feb.•17 min

Immune Thrombocytopenia — ASH 2025 Review

6 feb.•1 tim 30 min

Hematologic Oncology Update med Dr. Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.